(Q88516781)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

John Marquart

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Emerson Y Chen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Vinay Prasad

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

1 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

1093-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

25 March 2020

cites work

1 reference

12 December 2020

Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens

1 reference

12 December 2020

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

12 December 2020

Lung cancer: epidemiology, etiology, and prevention

1 reference

12 December 2020

Cancer statistics, 2013

1 reference

12 December 2020

Genomics-driven oncology: framework for an emerging paradigm

1 reference

12 December 2020

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014

1 reference

12 December 2020

Precision oncology: origins, optimism, and potential

1 reference

12 December 2020

Precision oncology: a strategy we were not ready to deploy.

1 reference

12 December 2020

No Solid Evidence, Only Hollow Argument for Universal Tumor Sequencing: Show Me the Data

1 reference

12 December 2020

Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study.

1 reference

12 December 2020

Genomic Alteration-Driven Clinical Trial Designs in Oncology

1 reference

12 December 2020

Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States

1 reference

12 December 2020

Can We Define and Reach Precise Goals for Precision Medicine in Cancer Care?

1 reference

12 December 2020

Perspective: The precision-oncology illusion

1 reference

12 December 2020

Toward a Shared Vision for Cancer Genomic Data

1 reference

12 December 2020

Limits to Personalized Cancer Medicine.

1 reference

12 December 2020

Implementing Genome-Driven Oncology

1 reference

12 December 2020

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

1 reference

12 December 2020

Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time

1 reference

12 December 2020

Functional precision cancer medicine-moving beyond pure genomics

1 reference

12 December 2020

Future cancer research priorities in the USA: a Lancet Oncology Commission

1 reference

12 December 2020

Why the US Centers for Medicare and Medicaid Services (CMS) should have required a randomized trial of Foundation Medicine (F1CDx) before paying for it

1 reference

12 December 2020

Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study.

1 reference

12 December 2020

10.1001/JAMAONCOL.2018.1660

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29710180%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

PubMed publication ID

29710180

1 reference